|
|
|
Volumn 28, Issue 4, 1996, Pages 2147-2150
|
|
Use of cyclosporine microemulsion (Neoral) in de novo and stable renal transplantation: Clinical impact, pharmacokinetic consequences and economic benefits
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
LYMPHOCYTE ANTIBODY;
PREDNISONE;
ADULT;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG COST;
EMULSION;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PHARMACOEPIDEMIOLOGY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, ORAL;
CANADA;
COSTS AND COST ANALYSIS;
CYCLOSPORINE;
DOUBLE-BLIND METHOD;
EMULSIONS;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINAL ABSORPTION;
KIDNEY TRANSPLANTATION;
PROSPECTIVE STUDIES;
|
|
EID: 0029840387
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (28)
|
|
References (0)
|
